Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Cirrus Logic
CRUS
$6.39B
| $2.98M | ﹤0.01% |
27,256
+5,249
| +24% | +$511K |
|
1877
Flowers Foods
FLO
$1.54B
| $2.98M | ﹤0.01% |
108,633
-4,663
| -4% | -$129K |
|
1878
Vanguard FTSE Pacific ETF
VPL
$8.11B
| $2.97M | ﹤0.01% |
43,749
+39,871
| +1,028% | +$2.68M |
|
|
DFS
1879
CALL
DELISTED
Discover Financial Services
DFS
| $2.97M | ﹤0.01% |
+30,000
| New | +$3.21M |
|
1880
Arcus Biosciences
RCUS
$3.47B
| $2.96M | ﹤0.01% |
162,451
+36,413
| +29% | +$696K |
|
1881
CNO Financial Group
CNO
$5.23B
| $2.96M | ﹤0.01% |
133,473
+11,502
| +9% | +$275K |
|
1882
Viridian Therapeutics
VRDN
$2.07B
| $2.95M | ﹤0.01% |
116,143
+16,823
| +17% | +$539K |
|
|
AKRO
1883
DELISTED
Akero Therapeutics
AKRO
| $2.95M | ﹤0.01% |
77,224
-26,328
| -25% | -$1.17M |
|
|
TRTX
1884
TPG RE Finance Trust
TRTX
$616M
| $2.95M | ﹤0.01% |
406,521
-102,661
| -20% | -$815K |
|
1885
Independent Bank
INDB
$4.05B
| $2.95M | ﹤0.01% |
44,960
+15,931
| +55% | +$1.22M |
|
1886
Materion
MTRN
$4.43B
| $2.94M | ﹤0.01% |
25,374
+15,473
| +156% | +$1.55M |
|
1887
Phillips Edison & Co
PECO
$5.41B
| $2.94M | ﹤0.01% |
90,168
+33,926
| +60% | +$1.11M |
|
1888
Camping World
CWH
$681M
| $2.92M | ﹤0.01% |
140,145
+51,343
| +58% | +$1.2M |
|
1889
H.B. Fuller
FUL
$3.04B
| $2.91M | ﹤0.01% |
42,512
+6,022
| +17% | +$420K |
|
|
UCB
1890
United Community Banks
UCB
$4.29B
| $2.91M | ﹤0.01% |
103,348
+24,807
| +32% | +$784K |
|
1891
Flywire
FLYW
$2.02B
| $2.9M | ﹤0.01% |
98,787
+74,444
| +306% | +$1.96M |
|
|
SMAR
1892
DELISTED
Smartsheet Inc.
SMAR
| $2.9M | ﹤0.01% |
60,628
+43,524
| +254% | +$1.89M |
|
|
BRSL
1893
Brightstar Lottery PLC
BRSL
$1.87B
| $2.89M | ﹤0.01% |
107,991
+11,972
| +12% | +$307K |
|
1894
XPO
XPO
$23B
| $2.89M | ﹤0.01% |
90,633
+33,882
| +60% | +$1.22M |
|
1895
Kilroy Realty
KRC
$4.56B
| $2.88M | ﹤0.01% |
88,944
-8,743
| -9% | -$319K |
|
1896
Fate Therapeutics
FATE
$291M
| $2.85M | ﹤0.01% |
500,822
+236,947
| +90% | +$1.43M |
|
1897
ZIM Integrated Shipping Services
ZIM
$3.14B
| $2.85M | ﹤0.01% |
120,931
-97,629
| -45% | -$2.05M |
|
1898
Steven Madden
SHOO
$3.51B
| $2.84M | ﹤0.01% |
78,778
+10,049
| +15% | +$348K |
|
1899
PUT
Virgin Galactic
SPCE
$359M
| $2.83M | ﹤0.01% |
35,000
| – | – |
|
1900
Avient
AVNT
$3.39B
| $2.83M | ﹤0.01% |
68,851
+38,251
| +125% | +$1.53M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.